z-logo
open-access-imgOpen Access
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
Author(s) -
Ingrid Engebretsen,
John Munkhaugen,
Christoffer Bugge,
Sigrun Halvorsen,
Kristina Malene Ødegaard,
Henrik Støvring,
Ivar Sønbø Kristiansen
Publication year - 2022
Publication title -
european heart journal open
Language(s) - English
Resource type - Journals
ISSN - 2752-4191
DOI - 10.1093/ehjopen/oeac070
Subject(s) - ezetimibe , discontinuation , medicine , statin , atorvastatin , simvastatin , medical prescription , evolocumab , rimonabant , rosuvastatin , drug , pharmacology , cholesterol , total cholesterol , receptor , apolipoprotein a1 , cannabinoid receptor , agonist

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom